Association of beta-2-microglobulin, cystatin C and lipocalin-2 with stroke risk in the general Chinese population

References

• World Health Organization. Stroke, cerebrovascular accident. [cited 2022 Oct 10]. Available from: https://www.emro.who.int/health-topics/stroke-cerebrovascular-accident/index.html
   Google Scholar
• Argyropoulos CP, Chen SS, Ng YH, et al. Rediscovering beta-2 microglobulin as a biomarker across the spectrum of kidney diseases. Front Med. 2017;4:1.
   Web of Science ®Google Scholar
• Inker LA, Schmid CH, Tighiouart H, et al. Estimating glomerular filtration rate from serum creatinine and cystatin C. N Engl J Med. 2012;367(1):20–8.
   PubMed Web of Science ®Google Scholar
• Wen Y, Parikh CR. Current concepts and advances in biomarkers of acute kidney injury. Crit Rev Clin Lab Sci. 2021;58(5):354–368.
   PubMed Web of Science ®Google Scholar
• Li Q, Zhang Y, Ding D, et al. Association between serum fibroblast growth factor 21 and mortality among patients with coronary artery disease. J Clin Endocrinol Metab. 2016;101(12):4886–4894.
   PubMed Web of Science ®Google Scholar
• Foster MC, Coresh J, Hsu CY, et al. Serum β-trace protein and β2-microglobulin as predictors of ESRD, mortality, and cardiovascular disease in adults with CKD in the chronic renal insufficiency cohort (CRIC) study. Am J Kidney Dis. 2016;68(1):68–76.
   PubMed Web of Science ®Google Scholar
• Lee M, Saver JL, Huang WH, et al. Impact of elevated cystatin C level on cardiovascular disease risk in predominantly high cardiovascular risk populations: a meta-analysis. Circ Cardiovasc Qual Outcomes. 2010;3(6):675–683.
   PubMed Web of Science ®Google Scholar
• Svensson-Färbom P, Almgren P, Hedblad B, et al. Cystatin C is not causally related to coronary artery disease. PLOS One. 2015;10(6):e0129269.
   PubMed Web of Science ®Google Scholar
• van der Laan SW, Fall T, Soumaré A, et al. Cystatin C and cardiovascular disease: a mendelian randomization study. J Am Coll Cardiol. 2016;68(9):934–945.
   PubMed Web of Science ®Google Scholar
• Fang Z, Deng J, Wu Z, et al. Cystatin C is a crucial endogenous protective determinant against stroke. Stroke. 2017;48(2):436–444.
   PubMed Web of Science ®Google Scholar
• Wong YK, Cheung CYY, Tang CS, et al. Age-biomarkers-clinical risk factors for prediction of cardiovascular events in patients with coronary artery disease. Arterioscler Thromb Vasc Biol. 2018;38(10):2519–2527.
   PubMed Web of Science ®Google Scholar
• Xiao W, Chen W, Hu H, et al. The clinical significance of neutrophil gelatinase-associated lipocalin in ischemic stroke patients with acute kidney injury. J Clin Lab Anal. 2019;33(6):e22907.
   PubMed Web of Science ®Google Scholar
• Hasegawa M, Ishii J, Kitagawa F, et al. Plasma neutrophil gelatinase-associated lipocalin as a predictor of cardiovascular events in patients with chronic kidney disease. Biomed Res Int. 2016;2016:8761475.
   PubMed Web of Science ®Google Scholar
• Wang W, Jiang B, Sun H, et al. Prevalence, incidence, and mortality of stroke in China: results from a nationwide population-based survey of 480 687 adults. Circulation. 2017;135(8):759–771.
   PubMed Web of Science ®Google Scholar
• Stroke Prevention Project Committee. Programmeme of stroke screening and Intervention for high-risk population. 2022. Available from: http://cnstroke.com/WebManage/InterveneProject/Index
   Google Scholar
• Benoit SW, Ciccia EA, Devarajan P. Cystatin C as a biomarker of chronic kidney disease: latest developments. Expert Rev Mol Diagn. 2020;20(10):1019–1026.
   PubMed Web of Science ®Google Scholar
• Chen JJ, Lee TH, Lee CC, et al. Using lipocalin as a prognostic biomarker in acute kidney injury. Expert Rev Mol Diagn. 2021;21(5):455–464.
   PubMed Web of Science ®Google Scholar
• Rist PM, Jiménez MC, Rexrode KM. Prospective association between β(2)-microglobulin levels and ischemic stroke risk among women. Neurology. 2017;88(23):2176–2182.
   PubMed Web of Science ®Google Scholar
• Rebholz CM, Grams ME, Matsushita K, et al. Change in multiple filtration markers and subsequent risk of cardiovascular disease and mortality. Clin J Am Soc Nephrol. 2015;10(6):941–948.
   PubMed Web of Science ®Google Scholar
• Shi F, Sun L, Kaptoge S. Association of beta-2-microglobulin and cardiovascular events and mortality: a systematic review and meta-analysis. Atherosclerosis. 2021;320:70–78.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Yang S, Chen J, et al. Associations of serum cystatin C and its change with new-onset cardiovascular disease in Chinese general population. Nutr Metab Cardiovasc Dis. 2022;32(8):1963–1971.
   PubMed Web of Science ®Google Scholar
• Winovich DT, Longstreth WTJr, Arnold AM, et al. Factors associated with ischemic stroke survival and recovery in older adults. Stroke. 2017;48(7):1818–1826.
   PubMed Web of Science ®Google Scholar
• Kunutsor SK, Flores-Guerrero JL, Kieneker LM, et al. Plasma neutrophil gelatinase-associated lipocalin and risk of cardiovascular disease: findings from the PREVEND prospective cohort study. Clin Chim Acta. 2018;486:66–75.
   PubMed Web of Science ®Google Scholar
• Li C, Zhang Z, Peng Y, et al. Plasma neutrophil gelatinase-associated lipocalin levels are associated with the presence and severity of coronary heart disease. PLOS One. 2019;14(8):e0220841.
   PubMed Web of Science ®Google Scholar
• West M, Kirby A, Stewart RA, et al. Circulating cystatin C is an independent risk marker for cardiovascular outcomes, development of renal impairment, and long-term mortality in patients with stable coronary heart disease: the LIPID study. J Am Heart Assoc. 2022;11(5):e020745.
   PubMed Web of Science ®Google Scholar
• Kang W. Malvaso A. Understanding cognitive deficits in people with coronary heart disease (CHD). J Pers Med. 2023;13(2):307.
   Web of Science ®Google Scholar
• Loew M, Hoffmann MM, Koenig W, et al. Genotype and plasma concentration of cystatin C in patients with coronary heart disease and risk for secondary cardiovascular events. Arterioscler Thromb Vasc Biol. 2005;25(7):1470–1474.
   PubMed Web of Science ®Google Scholar
• Akerblom A, Eriksson N, Wallentin L, et al. Polymorphism of the cystatin C gene in patients with acute coronary syndromes: results from the PLATelet inhibition and patient outcomes study. Am Heart J. 2014;168(1):96–102.e2.
   PubMed Web of Science ®Google Scholar
• Marques FZ, Prestes PR, Byars SG, et al. Experimental and human evidence for lipocalin-2 (neutrophil gelatinase-associated lipocalin [NGAL]) in the development of cardiac hypertrophy and heart failure. J Am Heart Assoc. 2017;6(6):e005971.
   PubMed Web of Science ®Google Scholar
• Ong KL, Tso AW, Cherny SS, et al. Role of genetic variants in the gene encoding lipocalin-2 in the development of elevated blood pressure. Clin Exp Hypertens. 2011;33(7):484–491.
   PubMed Web of Science ®Google Scholar
• Ardeniz Ö, Unger S, Onay H, et al. β2-Microglobulin deficiency causes a complex immunodeficiency of the innate and adaptive immune system. J Allergy Clin Immunol. 2015;136(2):392–401.
   PubMed Web of Science ®Google Scholar
• Xie J, Yi Q. Beta2-microglobulin as a potential initiator of inflammatory responses. Trends Immunol. 2003;24(5):228–229.
   PubMed Web of Science ®Google Scholar
• Amighi J, Hoke M, Mlekusch W, et al. Beta 2 microglobulin and the risk for cardiovascular events in patients with asymptomatic carotid atherosclerosis. Stroke. 2011;42(7):1826–1833.
   PubMed Web of Science ®Google Scholar
• Liu J, Sukhova GK, Sun JS, et al. Lysosomal cysteine proteases in atherosclerosis. Arterioscler Thromb Vasc Biol. 2004;24(8):1359–1366.
   PubMed Web of Science ®Google Scholar
• Zi M, Xu Y. Involvement of cystatin C in immunity and apoptosis. Immunol Lett. 2018;196:80–90.
   PubMed Web of Science ®Google Scholar
• Te Boekhorst BC, Bovens SM, Hellings WE, et al. Molecular MRI of murine atherosclerotic plaque targeting NGAL: a protein associated with unstable human plaque characteristics. Cardiovasc Res. 2011;89(3):680–688.
   PubMed Web of Science ®Google Scholar
• Song E, Fan P, Huang B, et al. Deamidated lipocalin-2 induces endothelial dysfunction and hypertension in dietary obese mice. J Am Heart Assoc. 2014;3(2):​e000837.
   PubMed Web of Science ®Google Scholar
• Ferreira AC, Sousa N, Bessa JM, et al. Metabolism and adult neurogenesis: towards an understanding of the role of lipocalin-2 and iron-related oxidative stress. Neurosci Biobehav Rev. 2018;95:73–84.
   PubMed Web of Science ®Google Scholar
• Althubiti M, Elzubier M, Alotaibi GS, et al. Beta 2 microglobulin correlates with oxidative stress in elderly. Exp Gerontol. 2021;150:111359.
   PubMed Web of Science ®Google Scholar
• Allen CL, Bayraktutan U. Oxidative stress and its role in the pathogenesis of ischaemic stroke. Int J Stroke. 2009;4(6):461–470.
   PubMed Web of Science ®Google Scholar
• Li H, Zhang N, Lin HY, et al. Histological, cellular and behavioral assessments of stroke outcomes after photothrombosis-induced ischemia in adult mice. BMC Neurosci. 2014;15:58.
   PubMed Web of Science ®Google Scholar